ShadowBuys
Sign inJoin for free
Committee overlap: HELP

Sen. Tommy Tuberville sold Pfizer (PFE)

Sen. Tommy Tuberville (R-AL) · $15K–$50K · traded Jun 8, 2026

Why this is a committee overlap

Tuberville is a member of the Senate Committee on Health, Education, Labor, and Pensions, which oversees the Healthcare sector. Pfizer is classified in the Drug Manufacturers - General industry.

An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.

Transaction
Sold (full)
Amount
$15K–$50K
Owner
Joint
Traded
Jun 8, 2026
Disclosed
Jul 16, 2026
Days to disclose
38
Asset type
Stock
As filed
Pfizer, Inc. Common Stock
Industry
Drug Manufacturers - General · Healthcare
Official filing ↗All of Tuberville's tradesAll Congress trades in PFE

Other trades in this filing

Recent Congress trades in PFE

Company context for PFE

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. PFECompany announcement·SEC EDGAR

    PFE: Leadership change

    Filed 8-K for an event or period dated 2026-10-30. Leadership change.

    Public: Nov 3, 2026, 4:19 PM ESTEvent / period: Oct 30, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. PFEFinancial report·SEC EDGAR

    PFE: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-27. Read the company report for its disclosures.

    Public: Nov 3, 2026, 8:19 AM ESTEvent / period: Sep 27, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. PFECompany announcement·SEC EDGAR

    PFE: Financial results

    Filed 8-K for an event or period dated 2026-11-03. Financial results.

    Public: Nov 3, 2026, 8:07 AM ESTEvent / period: Nov 3, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.